Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gammaplex in chronic idiopathic thrombocytopenic purpura
NCT00504075Phase 3Completed
- Sponsor
- Bio Products Laboratory
- Start
- Sep 2007
- Primary completion
- Aug 2011
- Countries
- 3
01
Overview
Phase 3, open-label trial of intravenous immunoglobulin G in immune thrombocytopenia (ITP), sponsored by Bio Products Laboratory. Primary endpoint: Number of Subjects With Chronic ITP Treated With Gammaplex Whose Platelet Count Reached a Threshold of 50 x 10^9/L at 9 days. Started Sep 2007; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00504075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504075.